Vascular Medicine

Top Story

Ralinepag improves pulmonary vascular resistance in PAH

Ralinepag improves pulmonary vascular resistance in PAH
November 17, 2017

Patients with pulmonary artery hypertension who were treated with ralinepag in addition to single or dual background therapy had improved pulmonary vascular resistance compared with those treated with placebo, according to data presented at the CHEST annual meeting.

“It was ... a clinically meaningful effect that portends an improvement through something that would correspond in most cases with an improvement in terms of their symptoms, but more importantly in terms of their long-term outcomes,” Vallerie V. McLaughlin, MD, professor at University of Michigan Medical School in Ann Arbor, told Cardiology Today.

Meeting News

Experts: Hypertension guideline sound, but implementation challenges ahead

November 17, 2017
ANAHEIM, Calif. — Hypertension experts interviewed by Cardiology Today praised the new American Heart Association/American College of Cardiology hypertension…
FDA News

FDA to examine heart-related deaths associated with febuxostat

November 16, 2017
The FDA announced that preliminary data from a safety trial demonstrate that, compared with allopurinol, febuxostat is linked to an increased risk for heart-related…
Meeting NewsPerspective

PROPEL: Cell therapy does not boost walking performance in PAD

November 16, 2017
ANAHEIM, Calif. — In patients with peripheral artery disease in the PROPEL trial, granulocyte-macrophage colony-stimulating factor, either alone or in combination…
More Headlines »
CNE CME CPE

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and…
More »
Video
Meeting News

VIDEO: Certain antiplatelet therapies more beneficial for patients with vs. without diabetes

July 15, 2017
More »
Resource Centers
American Heart Association Scientific Sessions

American Heart Association Scientific Sessions

Video
Meeting News

VIDEO: Speaker highlights importance of diagnosing patients with EPGA and cardiac manifestations

April 5, 2017
More »
Advertisement
Advertisement